CARLSBAD, Calif., Sept. 8, 2022 /PRNewswire/ — Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer, today announced that management will participate at…
News Ticker
- [ June 5, 2023 ] Supervisor, Laboratory – Bio-techne – San Marcos, CA San Diego Biotech Jobs
- [ June 5, 2023 ] UC San Diego Health Recognized for Leadership in Environmental Sustainability News
- [ June 5, 2023 ] Cali Biosciences Initiates Second Phase III Study of CPL-01 (Long-Acting Ropivacaine) to Decrease Post-Operative Pain and Reduce or Eliminate Opioid Use and Presents Consistent and Predictable PK Results Across Multiple Surgeries News
- [ June 5, 2023 ] Wounded Warrior Project to Team Up with VA to Empower Veterans at Adaptive Sports Clinic News
- [ June 5, 2023 ] Pumping the brakes on autoimmune disease News
Copyright © 2023 Biotech Networks, LLC
